177 related articles for article (PubMed ID: 14579093)
1. Reduction of 99mTc-sestamibi and 99mTc-tetrofosmin uptake in MRP-expressing breast cancer cells under hypoxic conditions is independent of MRP function.
Kinuya S; Li XF; Yokoyama K; Mori H; Shiba K; Watanabe N; Shuke N; Bunko H; Michigishi T; Tonami N
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1529-31. PubMed ID: 14579093
[TBL] [Abstract][Full Text] [Related]
2. Limitations of (99m)Tc tetrofosmin in assessing reversal effects of verapamil on the function of multi-drug resistance associated protein 1.
Kinuya S; Li XF; Yokoyama K; Mori H; Shiba K; Watanabe N; Shuke N; Bunko H; Michigishi T; Tonami N
Nucl Med Commun; 2004 Jun; 25(6):585-9. PubMed ID: 15167518
[TBL] [Abstract][Full Text] [Related]
3. Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin.
Liu Z; Stevenson GD; Barrett HH; Furenlid LR; Wilson DW; Kastis GA; Bettan M; Woolfenden JM
Nucl Med Biol; 2005 Aug; 32(6):573-83. PubMed ID: 16026704
[TBL] [Abstract][Full Text] [Related]
4. 99mTc-sestamibi to monitor treatment with antisense oligodeoxynucleotide complementary to MRP mRNA in human breast cancer cells.
Kinuya S; Bai J; Shiba K; Yokoyama K; Mori H; Fukuoka M; Watanabe N; Shuke N; Michigishi T; Tonami N
Ann Nucl Med; 2006 Jan; 20(1):29-34. PubMed ID: 16485571
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein versus MRP1 on transport kinetics of cationic lipophilic substrates: a comparative study using [99mTc]sestamibi and [99mTc]tetrofosmin.
Gomes CM; Abrunhosa AJ; Pauwels EK; Botelho MF
Cancer Biother Radiopharm; 2009 Apr; 24(2):215-27. PubMed ID: 19409044
[TBL] [Abstract][Full Text] [Related]
6. Effect of asiaticoside on 99mTc-tetrofosmin and 99mTc-sestamibi uptake in MCF-7 cells.
Al-Saeedi FJ; Bitar M; Pariyani S
J Nucl Med Technol; 2011 Dec; 39(4):279-83. PubMed ID: 22080437
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-induced alteration of tracer accumulation in cultured cancer cells and xenografts in mice: implications for pre-therapeutic prediction of treatment outcomes with (99m)Tc-sestamibi, (201)Tl chloride and (99m)Tc-HL91.
Kinuya S; Yokoyama K; Li XF; Bai J; Watanabe N; Shuke N; Takayama T; Bunko H; Michigishi T; Tonami N
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1006-11. PubMed ID: 12173013
[TBL] [Abstract][Full Text] [Related]
8. Different Efflux Transporter Affinity and Metabolism of
Kobayashi M; Tsujiuchi T; Okui Y; Mizutani A; Nishi K; Nakanishi T; Nishii R; Fukuchi K; Tamai I; Kawai K
Pharm Res; 2018 Nov; 36(1):18. PubMed ID: 30498970
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the accumulation and efflux kinetics of technetium-99m sestamibi and technetium-99m tetrofosmin in an MRP-expressing tumour cell line.
Utsunomiya K; Ballinger JR; Piquette-Miller M; Rauth AM; Tang W; Su ZF; Ichise M
Eur J Nucl Med; 2000 Dec; 27(12):1786-92. PubMed ID: 11189941
[TBL] [Abstract][Full Text] [Related]
10. The breast cancer cell line MCF7 as a model of 99mTc-SestaMIBI, 99mTc-tetrofosmin and 99mTc-Medronate incorporation.
Molteni SN; Seregni E; Botti C; Martinetti A; Ferrari L; Crippa F; Bombardieri E
Anticancer Res; 1999; 19(1A):255-9. PubMed ID: 10226551
[TBL] [Abstract][Full Text] [Related]
11. Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells.
Moretti JL; Duran Cordobes M; Starzec A; de Beco V; Vergote J; Benazzouz F; Boissier B; Cohen H; Safi N; Piperno-Neumann S; Kouyoumdjian JC
J Nucl Med; 1998 Jul; 39(7):1214-8. PubMed ID: 9669397
[TBL] [Abstract][Full Text] [Related]
12. Malignant gliomas display altered plasma membrane potential and pH regulation--interaction with Tc-99m-MIBI and Tc-99m-Tetrofosmin uptakes.
Perek N; Denoyer D; Dubois F; Koumanov F
Gen Physiol Biophys; 2002 Dec; 21(4):381-404. PubMed ID: 12693711
[TBL] [Abstract][Full Text] [Related]
13. Study of monoglutathionyl conjugates TC-99M-sestamibi and TC-99M-tetrofosmin transport mediated by the multidrug resistance-associated protein isoform 1 in glioma cells.
Le Jeune N; Perek N; Denoyer D; Dubois F
Cancer Biother Radiopharm; 2005 Jun; 20(3):249-59. PubMed ID: 15989470
[TBL] [Abstract][Full Text] [Related]
14. Uptake of 99mTc-MIBI and 99mTc-tetrofosmin into malignant versus nonmalignant breast cell lines.
Rodrigues M; Chehne F; Kalinowska W; Berghammer P; Zielinski C; Sinzinger H
J Nucl Med; 2000 Sep; 41(9):1495-9. PubMed ID: 10994728
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G
J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
[TBL] [Abstract][Full Text] [Related]
16. Influence of glutathione depletion on plasma membrane cholesterol esterification and on Tc-99m-sestamibi and Tc-99m-tetrofosmin uptakes: a comparative study in sensitive U-87-MG and multidrug-resistant MRP1 human glioma cells.
Le Jeune N; Perek N; Denoyer D; Dubois F
Cancer Biother Radiopharm; 2004 Aug; 19(4):411-21. PubMed ID: 15453956
[TBL] [Abstract][Full Text] [Related]
17. 99mTc glucarate high-resolution imaging of drug sensitive and drug resistant human breast cancer xenografts in SCID mice.
Liu Z; Stevenson GD; Barrett HH; Kastis GA; Bettan M; Furenlid LR; Wilson DW; Woolfenden JM; Pak KY
Nucl Med Commun; 2004 Jul; 25(7):711-20. PubMed ID: 15208499
[TBL] [Abstract][Full Text] [Related]
18. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines.
Arbab AS; Koizumi K; Toyama K; Araki T
J Nucl Med; 1996 Sep; 37(9):1551-6. PubMed ID: 8790217
[TBL] [Abstract][Full Text] [Related]
19. Comparative 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin uptake in human soft tissue sarcoma cell lines.
Rodriques M; Chehne F; Kalinowska W; Zielinski C; Sinzinger H
Eur J Nucl Med; 2000 Dec; 27(12):1839-43. PubMed ID: 11189948
[TBL] [Abstract][Full Text] [Related]
20. 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 in vitro and in vivo.
Bernard BF; Krenning EP; Breeman WA; Ensing G; Benjamins H; Bakker WH; Visser TJ; de Jong M
Nucl Med Biol; 1998 Apr; 25(3):233-40. PubMed ID: 9620628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
